The US Drug Enforcement Administration is temporarily suspending Cardinal Health's license to distribute controlled substances from its Auburn, Washington distribution center.
Subscribe to our email newsletter
The company said the suspension affects only the Washington facility and only controlled substance shipments from that facility. Steps are being taken to ensure continuity of service to its customers.
The Drug Enforcement Administration (DEA) said that Cardinal Health “failed to maintain effective controls against the diversion of a particular controlled substance,” and cites the sale of hydrocodone, a painkiller, to one pharmacy that allegedly dispensed excessive amounts of the drug based on illegitimate prescriptions from internet pharmacy web sites.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.